Founded in 2019, Tetrous, Inc. utilizes next generation advanced technologies for enthesis repair in sports medicine applications. The first offerings in the EnFix family of products are EnFix RC and EnFix TAC for a wide range of anatomical entheses including rotator cuff repair, proximal/distal biceps tenodesis, insertional Achilles tendinopathy, gluteus medius and proximal hamstring reattachment, lateral epicondyle repair, and subscapularis repair during total shoulder arthroplasty. Tetrous was conceived from technology developed for spine surgery. The Company is employing and expanding the technology for novel applications in sports medicine. Its core technology has been used in over 150,000 implants in spine applications and thousands of implants in sports medicine applications. Tetrous enjoys significant IP protection for its EnFix family of products with multiple issued patents as well as exclusive licenses to the demineralized bone fiber technology used in its products for sports medicine.